Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-25-073669
Filing Date
2025-08-08
Accepted
2025-08-08 16:15:06
Documents
3
Period of Report
2025-08-08

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea025244901-6k_ascentage.htm 6-K 10322
2 ANNOUNCEMENT DATED AUGUST 8, 2025 ea025244901ex99-1_ascentage.htm EX-99.1 4641
3 GRAPHIC image_003.jpg GRAPHIC 5121
  Complete submission text file 0001213900-25-073669.txt   23265
Mailing Address 68 XINQING ROAD SUZHOU INDUSTRIAL PARK SUZHOU , JIANGSU F4 00000
Business Address 68 XINQING ROAD SUZHOU INDUSTRIAL PARK SUZHOU , JIANGSU F4 00000 86 512 8555 7777
ASCENTAGE PHARMA GROUP INTERNATIONAL (Filer) CIK: 0002023311 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-42484 | Film No.: 251198588
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)